Skip to main content
. 2017 Jun 6;2017(6):CD012143. doi: 10.1002/14651858.CD012143.pub2

Analysis 3.19.

Analysis 3.19

Comparison 3 DAA on or on the way to the market versus placebo/no intervention, Outcome 19 Without sustained virological response ‐ 'Worst‐best case' scenario.